MCT’s collaboration with Onxeo on HCC Phase III study in Middle East

/ News /

Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon, Egypt and Saudi Arabia). More information in Onxeo press release: 150326EN_Livatag

Related Posts

New Quality Manager

News /

MCT is pleased to communicate about recruitment of a new Quality Manager. Quality Manager has started on 01/09/13 in Beirut/ Lebanon and will be focused…